- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Phenylketonuria (PKU)
- Meeting Date: March 2026
- Public Summary Document (PSD) March 2026 PBAC Meeting - (PDF)
- Public Summary Document (PSD) March 2026 PBAC Meeting - (DOCX)
Pegvaliase – March 2026
Injection 2.5 mg in 0.5 mL pre-filled syringe, Injection 10 mg in 0.5 mL pre-filled syringe, Injection 20 mg in 1 mL pre-filled syringe
Last updated
11 March 2026
